These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10667856)

  • 1. Synthesis and immunological studies of alpha-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV gD protein.
    Mezo G; Drakopoulou E; Paál V; Rajnavölgyi E; Vita C; Hudecz F
    J Pept Res; 2000 Jan; 55(1):7-17. PubMed ID: 10667856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibody recognition of mucin 1 (MUC1)-alpha-conotoxin chimera.
    Drakopoulou E; Uray K; Mezö G; Price MR; Vita C; Hudecz F
    J Pept Sci; 2000 Apr; 6(4):175-85. PubMed ID: 10809390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of linear, branched, and cyclic peptide chimera.
    Mezö G; Hudecz F
    Methods Mol Biol; 2005; 298():63-76. PubMed ID: 16044540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational study of linear and cyclic peptides corresponding to the 276-284 epitope region of HSV gD-1.
    Meźó G; Majer Z; Vass E; Jimenez MA; Andreu D; Hudecz F
    Biophys Chem; 2003 Jan; 103(1):51-65. PubMed ID: 12504254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of the 273-284 region of HSV glycoprotein D by synthetic branched polypeptide carrier conjugates.
    Hudecz F; Hilbert A; Mezö G; Mucsi I; Kajtár J; Bösze S; Kurucz I; Rajnavölgyi E
    Pept Res; 1993; 6(5):263-71. PubMed ID: 7504960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
    Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
    J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and structure-forming properties of the two disulfide bonds of alpha-conotoxin GI.
    Kaerner A; Rabenstein DL
    Biochemistry; 1999 Apr; 38(17):5459-70. PubMed ID: 10220333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of cyclic Herpes simplex virus peptides containing 281-284 epitope of glycoprotein D-1 in endo- or exo-position.
    Mezö G; Majer Z; Valero ML; Andreu D; Hudecz F
    J Pept Sci; 1999 Jun; 5(6):272-82. PubMed ID: 10463782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability.
    Gehrmann J; Alewood PF; Craik DJ
    J Mol Biol; 1998 May; 278(2):401-15. PubMed ID: 9571060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a herpes B virus-specific glycoprotein d immunodominant epitope recognized by natural and foreign hosts.
    Perelygina L; Zurkuhlen H; Patrusheva I; Hilliard JK
    J Infect Dis; 2002 Aug; 186(4):453-61. PubMed ID: 12195371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.
    Dolter KE; Goins WF; Levine M; Glorioso JC
    J Virol; 1992 Aug; 66(8):4864-73. PubMed ID: 1378512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of synthetic analogues of linear-epitope peptides of glycoprotein D of herpes simplex virus type 1 by surface plasmon resonance.
    Lasonder E; Schellekens GA; Koedijk DG; Damhof RA; Welling-Wester S; Feijlbrief M; Scheffer AJ; Welling GW
    Eur J Biochem; 1996 Aug; 240(1):209-14. PubMed ID: 8797855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fv structure of monoclonal antibody II-481 against herpes simplex virus Fc gamma-binding glycoprotein gE contains immunodominant complementarity determining region epitopes that react with human immunoglobulin M rheumatoid factors.
    Johansson PJ; Malone C; Swietnicki W; Dunn BM; Williams RC
    J Exp Med; 1994 Nov; 180(5):1873-88. PubMed ID: 7964464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.
    Isola VJ; Eisenberg RJ; Siebert GR; Heilman CJ; Wilcox WC; Cohen GH
    J Virol; 1989 May; 63(5):2325-34. PubMed ID: 2467994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library.
    Schellekens GA; Lasonder E; Feijlbrief M; Koedijk DG; Drijfhout JW; Scheffer AJ; Welling-Wester S; Welling GW
    Eur J Immunol; 1994 Dec; 24(12):3188-93. PubMed ID: 7805747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.